# National Institute of Allergy and Infectious Diseases: portfolio, investments and team

> National Institute of Allergy and Infectious Diseases is an investment firm based in United States.

Source: https://millionrounds.com/fund/national-institute-of-allergy-and-infectious-diseases (Millionrounds; every figure on the page links to its filing or article)

United States · [Investor](https://millionrounds.com/investors)

# National Institute of Allergy and Infectious Diseases

Last cheque observed Sep 2026; 43 cheques on record.

Deploying now Investment firm

Grant Venture Series B Biotechnology Health Care

Deploying now

**50%** of best year **5** **cheques in 12 months**, 43 on record

Since the last cheque **55** days **00** hrs **00** min **00** sec

Median round **$2.7M** Rounds led **0 of 43** Sole investor **18 rounds** Mostly in **United States, 97%**

Pitch National Institute of Allergy and Infectious Diseases

## National Institute of Allergy and Infectious Diseases highlights

- 01 5 cheques in the last 12 months
- 02 Mostly Grant and Venture: 88% of its rounds
- 03 Sole investor in 18 rounds, median $2.9M

## What they do

- **Type:** Investment firm (from a list, unverified)
- **Cheque size:** Not stated
- **Sectors:** Biotechnology Health Care
- **Based in:** Rockville, United States
- **Cold pitches:** Not stated

## The record

Every round we can evidence, newest first **43 appearances**

- **2026** 3 rounds
- **Sept** **[HDT Bio](https://millionrounds.com/company/hdt-bio)** Grant · US **$5.2M** With 1 other
- **Apr** **[ReAlta Life Sciences](https://millionrounds.com/company/realta-life-sciences)** Venture · US **$40M** Sole investor
- **Feb** **[ILiAD Biotechnologies](https://millionrounds.com/company/iliad-biotechnologies)** Series D · US **$115M** With 3 others
- **2025** 9 rounds
- **Dec** **[Trethera](https://millionrounds.com/company/trethera)** Grant · US **$2.7M** With 2 others
- **Nov** **[Daré Bioscience](https://millionrounds.com/company/dare-bioscience)** Grant · US **$3.6M** Sole investor
- **Sept** **[Lactiga](https://millionrounds.com/company/lactiga)** Venture · US **Undisclosed** With 3 others
- **Sept** **[Sunflower Therapeutics](https://millionrounds.com/company/sunflower-therapeutics)** Grant · US **$300K** Sole investor
- **Sept** **[Scanogen](https://millionrounds.com/company/scanogen)** Grant · US **$2.9M** Sole investor
- **Jun** **[MiNK Therapeutics](https://millionrounds.com/company/mink-therapeutics)** Venture · US **Undisclosed** Sole investor
- **May** **[Versatope Therapeutics](https://millionrounds.com/company/versatope-therapeutics)** Grant · US **$200K** With 2 others
- **May** **[Calder Biosciences](https://millionrounds.com/company/calder-biosciences)** Venture · US **Undisclosed** With 2 others
- **Mar** **[Osivax](https://millionrounds.com/company/osivax)** Series B · FR **$11M** With 2 others
- **2024** 9 rounds
- **Sept** **[Resvita Bio](https://millionrounds.com/company/resvita-bio)** Grant · US **$2.0M** With 2 others
- **Aug** **[Acenxion Biosystems](https://millionrounds.com/company/acenxion-biosystems)** Seed · US **$1.1M** Sole investor
- **Aug** **[Aldatu Biosciences](https://millionrounds.com/company/aldatu-biosciences)** Grant · US **$3.0M** With 2 others
- **Aug** **[Moonlight Therapeutics](https://millionrounds.com/company/moonlight-therapeutics)** Venture · US **$2.4M** With 1 other
- **Jun** **[Clairyon](https://millionrounds.com/company/clairyon)** Grant · US **$1.0M** Sole investor
- **Apr** **[TFF Pharmaceuticals](https://millionrounds.com/company/tff-pharmaceuticals)** US **$4.8M** Sole investor
- **Mar** **[Siolta Therapeutics](https://millionrounds.com/company/siolta-therapeutics)** Series C · US **$12M** With 3 others
- **Mar** **[Phase Genomics](https://millionrounds.com/company/phase-genomics)** Grant · US **$1.5M** With 4 others
- **Feb** **[Blacksmith Medicines](https://millionrounds.com/company/blacksmith-medicines)** Grant · US **$3.3M** With 2 others
- **2023** 9 rounds
- **Oct** **[HDT Bio](https://millionrounds.com/company/hdt-bio)** Grant · US **$1.0M** With 1 other
- **Sept** **[Omniose](https://millionrounds.com/company/omniose)** Grant · US **$3.0M** With 2 others
- **Aug** **[Ceramedix Holding](https://millionrounds.com/company/ceramedix-holding)** Grant · US **$3.0M** Sole investor
- **Aug** **[Exavir Therapeutics](https://millionrounds.com/company/exavir-therapeutics)** Grant · US **$3.0M** With 2 others
- **May** **[Sapience Therapeutics](https://millionrounds.com/company/sapience-therapeutics)** Grant · US **$2.0M** Sole investor
- **May** **[Integrated BioTherapeutics](https://millionrounds.com/company/integrated-biotherapeutics)** Venture · US **$1.0M** With 1 other
- **May** **[Truly Technologies](https://millionrounds.com/company/truly-technologies)** Grant · US **$273K** Sole investor
- **Jan** **[Iaso Therapeutics](https://millionrounds.com/company/iaso-therapeutics)** Grant · US **$125K** With 3 others
- **Jan** **[InDevR](https://millionrounds.com/company/indevr)** Series B · US **$9.0M** With 1 other
- **2022** 4 rounds
- **Nov** **[Kovina Therapeutics](https://millionrounds.com/company/kovina-therapeutics)** Grant · US **$275K** With 2 others
- **Aug** **[Institute for Bioscience and Biotechnology Research](https://millionrounds.com/company/institute-for-bioscience-and-biotechnology-research)** Grant · US **$6.9M** Sole investor
- **Aug** **[Melax Technologies](https://millionrounds.com/company/melax-technologies)** Grant · US **$300K** With 1 other
- **Jul** **[Intact Genomics](https://millionrounds.com/company/intact-genomics)** Grant · US **$2.9M** With 1 other
- **2021** 2 rounds
- **May** **[Nirvana Science, Inc.](https://millionrounds.com/company/nirvana-science-inc)** Venture **$867K** With 2 others
- **Jan** **[Kephera Diagnostics](https://millionrounds.com/company/kephera-diagnostics)** Grant **$417K** Sole investor
- **2020** 1 round
- **Aug** **[Enrich Therapeutics](https://millionrounds.com/company/enrich-therapeutics)** Grant **$1.7M** With 2 others
- **2019** 3 rounds
- **Dec** **[Antibacterial Resistance Leadership Group (ARLG)](https://millionrounds.com/company/antibacterial-resistance-leadership-group-arlg)** Grant **$103M** Sole investor
- **Jun** **[Arisan Therapeutics](https://millionrounds.com/company/arisan-therapeutics)** Grant **$1.0M** Sole investor
- **Jan** **[Forge Therapeutics](https://millionrounds.com/company/forge-therapeutics)** Grant **$5.7M** With 1 other

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The cheque

Grant Venture Series B

Median round joined **$2.7M** the round, not its cheque Alone, median **$2.9M**

Led 0 of 43 rounds **0%**

- **Sole investor:** 18 rounds
- **Last cheque:** Sept 2026

Rounds by stage said on their site

- Grant *29*
- Venture *8*
- Series B *2*
- Seed *1*
- Series C *1*
- Series D *1*

Cheques by month Led Joined

Nov 2023 Oct 2026

Often in the room with

- [National Institutes of Health](https://millionrounds.com/fund/national-institutes-of-health) 12
- [MassChallenge](https://millionrounds.com/fund/masschallenge) 2
- [National Cancer Institute (NCI)](https://millionrounds.com/fund/national-cancer-institute-nci) 2

**Pitching National Institute of Allergy and Infectious Diseases?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as National Institute of Allergy and Infectious Diseases. A count of rooms they were both in, not a relationship either has claimed.

[**National Institutes of Health** Government **12** rounds together](https://millionrounds.com/fund/national-institutes-of-health)[**MassChallenge** Accelerator **2** rounds together](https://millionrounds.com/fund/masschallenge)[**National Cancer Institute (NCI)** Investment firm **2** rounds together](https://millionrounds.com/fund/national-cancer-institute-nci)

## Recently backed

The latest companies National Institute of Allergy and Infectious Diseases put money into.

[**HDT Bio** $5.2M · Sept 2026](https://millionrounds.com/company/hdt-bio)[**ReAlta Life Sciences** $40M · Apr 2026](https://millionrounds.com/company/realta-life-sciences)[**ILiAD Biotechnologies** $115M · Feb 2026](https://millionrounds.com/company/iliad-biotechnologies)[**Trethera** $2.7M · Dec 2025](https://millionrounds.com/company/trethera)[**Lactiga** Sept 2025](https://millionrounds.com/company/lactiga)[**Sunflower Therapeutics** $300K · Sept 2025](https://millionrounds.com/company/sunflower-therapeutics)

## Quick answers about National Institute of Allergy and Infectious Diseases

### What does National Institute of Allergy and Infectious Diseases invest in?

National Institute of Allergy and Infectious Diseases invests most often at Grant and Venture (88% of the rounds on record), in sectors such as Biotechnology and Health Care.

### How active is National Institute of Allergy and Infectious Diseases?

43 investments on record, 5 of them in the last 12 months. The most recent was in Sept 2026.

### What has National Institute of Allergy and Infectious Diseases invested in recently?

Its most recent investments on record: HDT Bio (Grant, Sept 2026), ReAlta Life Sciences (Venture, Apr 2026) and ILiAD Biotechnologies (Series D, Feb 2026).

### How big are National Institute of Allergy and Infectious Diseases's cheques?

The median round it joins is $2.7M.

### Does National Institute of Allergy and Infectious Diseases lead rounds?

Rarely, if at all: none of its 43 investments on record names it as the lead.

### Where does National Institute of Allergy and Infectious Diseases invest?

Most of the companies it backs are in the United States (97%).

### Is National Institute of Allergy and Infectious Diseases investing now?

Yes: it is actively investing, with 5 investments in the last 12 months.

### Who does National Institute of Allergy and Infectious Diseases invest alongside?

Most often National Institutes of Health (12 rounds together), MassChallenge (2 rounds together) and National Cancer Institute (NCI) (2 rounds together).

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=national-institute-of-allergy-and-infectious-diseases) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=national-institute-of-allergy-and-infectious-diseases)